Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A.

Evid Based Complement Alternat Med · 2019 · PMC6339762 · PMID 30723510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In this study, after the treatment of biochanin A, a decreasing trend of BGLAP level can be seen from the western-blot, which may also indicate the death of osteosarcoma cells.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.